Clade-Specific Evolution Mediated by HLA-B*57/5801 in Human Immunodeficiency Virus Type 1 Clade A1 p24

被引:12
|
作者
McKinnon, Lyle R. [1 ,2 ]
Capina, Rupert [4 ]
Peters, Harold [4 ]
Mendoza, Mark [4 ]
Kimani, Joshua [1 ,2 ]
Wachihi, Charles [1 ]
Kariri, Anthony [1 ]
Kimani, Makobu [1 ]
Richmond, Meika [2 ]
Kiazyk, Sandy Koesters [5 ]
Fowke, Keith R. [1 ,2 ]
Jaoko, Walter [1 ]
Luo, Ma [4 ]
Ball, T. Blake [1 ,2 ,3 ,5 ]
Plummer, Francis A. [1 ,2 ,4 ,5 ]
机构
[1] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[2] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
[4] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[5] Publ Hlth Agcy Canada, Natl Lab HIV Immunol, Winnipeg, MB, Canada
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
T-CELL RESPONSES; VIRAL REPLICATION CAPACITY; LONG-TERM NONPROGRESSORS; HIV-1; INFECTION; CROSS-REACTIVITY; ESCAPE MUTATIONS; HLA ALLELES; CLASS-I; GAG; EPITOPE;
D O I
10.1128/JVI.01236-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HLA-B*57-mediated selection pressure leads to a typical escape pathway in human immunodeficiency virus type 1 (HIV-1) CD8 epitopes such as TW10. Whether this T242N pathway is shared by all clades remains unknown. We therefore assessed the nature of HLA-B*57 selection in a large, observational Kenyan cohort where clades A1 and D predominate. While T242N was ubiquitous in clade D HLA-B*57(+) subjects, this mutation was rare (15%) in clade A1. Instead, P243T and I247L were selected by clade A1-infected HLA-B*57 subjects but not by HLA-B*5801(+) subjects. Our data suggest that clade A1 consensus proline at Gag residue 243 might represent an inherent block to T242N escape in clade A1. We confirmed immunologically that P243T and I247L likely represent escape mutations. HLA-B*57 evolution also differed between clades in the KF11 and IW9 epitopes. A better understanding of clade-specific evolution is important for the development of HIV vaccines in regions with multiple clades.
引用
收藏
页码:12636 / 12642
页数:7
相关论文
共 44 条
  • [21] Glycoprotein 96-Mediated Presentation of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Human Leukocyte Antigen Class I-Restricted Peptide and Humoral Immune Responses to HIV-1 p24
    Gong, XiaoYan
    Gai, WeiWei
    Xu, JunQiang
    Zhou, Wei
    Tien, Po
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (11) : 1595 - 1600
  • [22] Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS
    Samikkannu, Thangavel
    Agudelo, Marisela
    Gandhi, Nimisha
    Reddy, Pichili V. B.
    Saiyed, Zainulabedin M.
    Nwankwo, Donald
    Nair, Madhavan P. N.
    JOURNAL OF NEUROVIROLOGY, 2011, 17 (03) : 230 - 238
  • [23] Human immunodeficiency virus type-1 p24 sequence from an Indian strain: Expression in Escherichia coli and implications in diagnostics
    Gupta, SK
    Sengupta, J
    Bisht, R
    Bhatnagar, A
    Kaul, R
    GENE, 1997, 190 (01) : 27 - 30
  • [24] Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals
    Setiawan, Laurentia C.
    Gijsbers, Esther F.
    van Nuenen, Adrianus C.
    Kootstra, Neeltje A.
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 2372 - 2380
  • [25] Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS
    Samikkannu, Thangavel
    Rao, Kurapati V. K.
    Gandhi, Nimisha
    Saxena, Shailendra K.
    Nair, Madhavan P. N.
    JOURNAL OF NEUROVIROLOGY, 2010, 16 (04) : 255 - 263
  • [26] Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles
    Gudmundsdotter, L.
    Bernasconi, D.
    Hejdeman, B.
    Sandstrom, E.
    Alaeus, A.
    Lidman, K.
    Ensoli, B.
    Wahren, B.
    Butto, S.
    VACCINE, 2008, 26 (40) : 5182 - 5187
  • [27] Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein
    Kyobe, Samuel
    Mwesigwa, Savannah
    Nkurunungi, Gyaviira
    Retshabile, Gaone
    Egesa, Moses
    Katagirya, Eric
    Amujal, Marion
    Mlotshwa, Busisiwe C.
    Williams, Lesedi
    Sendagire, Hakim
    Kiragga, Dithan
    Mardon, Graeme
    Matshaba, Mogomotsi
    Hanchard, Neil A.
    Kyosiimire-Lugemwa, Jacqueline
    Robinson, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [28] Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China
    Li, Xiufen
    Wu, Yue
    Ren, Xuqi
    Deng, Shuyun
    Hu, Guifang
    Yu, Shouyi
    Tang, Shixing
    PLOS ONE, 2016, 11 (11):
  • [29] Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein
    Prado, Julia G.
    Honeyborne, Isobella
    Brierley, Ian
    Puertas, Maria Carmen
    Martinez-Picado, Javier
    Goulder, Philip J. R.
    JOURNAL OF VIROLOGY, 2009, 83 (02) : 1018 - 1025
  • [30] Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen
    Tang, Shixing
    Zhao, Jiangqin
    Storhoff, James J.
    Norris, Philip J.
    Little, Richard F.
    Yarchoan, Robert
    Stramer, Susan L.
    Patno, Tim
    Domanus, Marc
    Dhar, Arindam
    Mirkin, Chad A.
    Hewlett, Indira K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 231 - 237